Quick answer: latest quarter results, by ticker or company name

Reported Q: Q2 2024 Rev YoY: -98.8% EPS YoY: +7.9% Move: +15.53%

IMAC Holdings Inc

BACK

$0.0662 15.53%

Exchange OTC Sector Healthcare Industry Medical Care Facilities

Q2 2024

Published: Dec 18, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for BACK

Reported

Report Date

Dec 18, 2024

Quarter Q2 2024

Revenue

15.75K

YoY: -98.8%

EPS

-1.17

YoY: +7.9%

Market Move

+15.53%

Previous quarter: Q1 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Revenue of $0.02M down 98.8% year-over-year
EPS of $-1.17 increased by 7.9% from previous year
Gross margin of -357.2%
Net income of -1.38M
""Our focus remains on revitalizing our core services to improve patient engagement and drive revenues back to sustainable levels," stated CEO Jeff Ervin." - Jeff Ervin

BACK

IMAC Holdings Inc

Period Q2 2024

Currency USD

Report Type Quarterly Earnings

Generated Mar 30, 2026

Swipe to view all report sections

Executive Summary

In Q2 2024, IMAC Holdings Inc (BACK) reported significant financial challenges, characterized by a steep decline in revenue and substantial net losses. Revenue reached only $15,750, representing a staggering 98.83% year-over-year decrease. The company incurred a gross loss of $56,252, largely attributed to high operational expenses totaling $1,416,694. While management continues to emphasize leveraging its outpatient medical clinics for sports injuries and related services, the persistent operational losses indicate a critical juncture for the company's strategy in the competitive healthcare environment. Management expressed a commitment to refining cost control measures, albeit amidst declining patient volumes and market headwinds that necessitate a reevaluation of growth strategies.

Key Performance Indicators

Revenue

Decreasing

15.75K

QoQ: N/A | YoY: -98.83%

Gross Profit

Decreasing

-56.25K

-3.57% margin

QoQ: 62.55% | YoY: -104.82%

Operating Income

Decreasing

-1.40M

QoQ: -243.08% | YoY: -1.52%

Net Income

Increasing

-1.38M

QoQ: -239.72% | YoY: 1.42%

EPS

Increasing

-1.17

QoQ: -234.29% | YoY: 7.87%

Revenue Trend

Margin Analysis

Financial Highlights

Financial Performance: Revenue for Q2 2024 was $15,750, down from $1,347,975 a year prior. This decline translated into a gross profit margin of -3.57%, underscoring severe profitability challenges. Year-over-year decreases in key metrics were notable: gross profit dropped by over 104%, and operating income remains negative at -$1,401,944, reflecting an operating income ratio of -89.01%. Furthermore, the net income totaled -$1,383,404, equating to an EPS of -1.17.

Liquidity and Cash Flow: The current ratio of 0.269 exposes liquidity concerns, highlighting an increasingly strained cash position with only $890,610 in cash at the end of the quarter. The report details negative cash flow from operations at -$727,876, indicating ongoing operational difficulties exacerbated by rising general and administrative expenses.

Income Statement

Metric	Value	YoY Change	QoQ Change
Revenue	15.75K	-98.83%	N/A
Gross Profit	-56.25K	-104.82%	62.55%
Operating Income	-1.40M	-1.52%	-243.08%
Net Income	-1.38M	1.42%	-239.72%
EPS	-1.17	7.87%	-234.29%

Key Financial Ratios

Gross Profit Margin

Weak

-3.57%

Gross profit margin is below industry norms, profitability concerns

Operating Profit Margin

Weak

-89.01%

Operating margin is below industry norms, profitability concerns

Net Profit Margin

Weak

-87.84%

Net profit margin is below industry norms, profitability concerns

Return on Assets

Weak

-0.62%

Return on assets suggests inefficient capital allocation

Return on Equity

Strong

60.30%

Return on equity demonstrates excellent capital efficiency and value creation

Current Ratio

Concern

0.27

Current ratio below safe levels, potential liquidity risk

P/E Ratio

Negative

-0.39x

Negative earnings make P/E ratio not meaningful

Price to Book

Undervalued

-0.94x

Trading below book value, potential value opportunity or distressed

Historical Earnings Comparison

Period	Revenue ($M)	EPS ($)	YoY Growth	Report
Q1 2025	0.00	-1.08	+0.0%	View
Q4 2024	0.15	-3.22	+103.0%	View
Q3 2024	0.06	-1.56	-96.4%	View
Q2 2024	0.02	-1.17	-98.8%	View
Q1 2024	0.00	-0.35	+0.0%	View

IMAC Holdings Inc (BACK) Q2 2024 Earnings Report

Company Status Snapshot

Earnings Highlights

Executive Summary

Key Performance Indicators

Revenue Trend

Margin Analysis

Historical Earnings Comparison

More BACK Quarterly Reports

BACK

BACK

BACK

BACK

Q2 2024 Reports in Healthcare Sector

Related Financial Data

Sector Analysis: Healthcare

BACK Full Profile

BACK Financial Statements

Earnings Calendar